Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Registry Study of Odevixibat (Bylvay) in PFIC Patients in China
CTR20255202Phase 4Active
- Sponsor
- Albireo Pharma
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of odevixibat in progressive familial intrahepatic cholestasis (PFIC), sponsored by Albireo Pharma. Started Apr 2026; status: active.
02
Drugs
odevixibat
03
Conditions
progressive familial intrahepatic cholestasis (PFIC)
Beyond the preview
Go deeper on CTR20255202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255202.